UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058870
Receipt number R000066658
Scientific Title Association Between Cumulative Triple Low Duration (Intraoperative Hypotension, Low BIS Values, and Low Inhaled Anesthetic Concentrations) and Postoperative Outcomes and Preoperative Frailty in Patients Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Observational Study
Date of disclosure of the study information 2025/08/25
Last modified on 2025/08/22 18:00:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association Between Cumulative Triple Low Duration (Intraoperative Hypotension, Low BIS Values, and Low Inhaled Anesthetic Concentrations) and Postoperative Outcomes and Preoperative Frailty in Patients Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Observational Study

Acronym

Association between cumulative time of triple low (intraoperative hypotension, low BIS value, low inhaled anesthetic concentration) and postoperative outcomes, and preoperative frailty

Scientific Title

Association Between Cumulative Triple Low Duration (Intraoperative Hypotension, Low BIS Values, and Low Inhaled Anesthetic Concentrations) and Postoperative Outcomes and Preoperative Frailty in Patients Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Observational Study

Scientific Title:Acronym

Association between cumulative time of triple low (intraoperative hypotension, low BIS value, low inhaled anesthetic concentration) and postoperative outcomes, and preoperative frailty

Region

Japan


Condition

Condition

Severe aortic valve stenosis

Classification by specialty

Cardiology Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study investigates whether the cumulative duration of triple low (intraoperative hypotension, low BIS, and low anesthetic concentration) during anesthesia is associated with preoperative frailty and postoperative outcomes, such as delirium, complications, hospital stay, and 30-day mortality in elderly patients undergoing TAVI for severe aortic stenosis.

Basic objectives2

Others

Basic objectives -Others

relevance

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

CK-MB value the day after surgery

Key secondary outcomes

Duke Activity Status Index, Preoperative frailty index, Preoperative NT-proBNP value, Postoperative CK/CK-MB, Postoperative troponin value, Number of days in CCU, Number of days in hospital, 30-day mortality after surgery, Postoperative complications (Clavien-Dindo)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent planned transcatheter aortic valve implantation for severe aortic stenosis at our hospital between December 2023 and April 2025

Key exclusion criteria

1. Patients with missing BIS measurements during anesthesia for 15 minutes or more
2. Patients undergoing concurrent surgery
3. Patients with coexisting neuromuscular diseases

Target sample size

376


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Hino

Organization

Osaka Metropolitan University

Division name

Department of Anesthesiology

Zip code

545-8586

Address

1-5-7 Asahimachi, Abeno-ku, Osaka

TEL

0666452186

Email

HinoH@omu.ac.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Hino

Organization

Osaka Metropolitan University

Division name

Department of Anesthesiology

Zip code

545-8586

Address

1-5-7 Asahimachi, Abeno-ku, Osaka

TEL

0666452186

Homepage URL


Email

m1165192@yahoo.co.jp


Sponsor or person

Institute

Osaka Metropolitan University

Institute

Department

Personal name



Funding Source

Organization

Osaka Metropolitan University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Osaka Metropolitan University Graduate School of Medicine

Address

1-2-7 Asahimachi, Abeno-ku, Osaka

Tel

0666453456

Email

gr-a-knky-ethics@omu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2025 Year 08 Month 22 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Inclusion Criteria:
Patients who underwent elective transcatheter aortic valve implantation (TAVI) for severe aortic stenosis at our institution between May 2021 and June 2025.

Exclusion Criteria:
1. Patients with missing BIS measurements for more than 15 minutes during anesthesia
2. Patients undergoing concomitant surgery with TAVI
3. Patients with comorbid neuromuscular disorders


Management information

Registered date

2025 Year 08 Month 22 Day

Last modified on

2025 Year 08 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066658